MX373395B - Vacuna de haemophilus parasuis para serovar tipo cuatro. - Google Patents

Vacuna de haemophilus parasuis para serovar tipo cuatro.

Info

Publication number
MX373395B
MX373395B MX2016004178A MX2016004178A MX373395B MX 373395 B MX373395 B MX 373395B MX 2016004178 A MX2016004178 A MX 2016004178A MX 2016004178 A MX2016004178 A MX 2016004178A MX 373395 B MX373395 B MX 373395B
Authority
MX
Mexico
Prior art keywords
haemophilus parasuis
vaccine
serovar type
serovar
type
Prior art date
Application number
MX2016004178A
Other languages
English (en)
Inventor
Paulraj Kirubakaran Lawrence
Russell F Bey
Original Assignee
Newport Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Laboratories Inc filed Critical Newport Laboratories Inc
Publication of MX373395B publication Critical patent/MX373395B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una vacuna de Haemophilus parasuis contra serovar tipo 4 capaz de activar una respuesta inmune protectora cuando se administra a cerdos como una vacuna de virus muertos. La presente invención también se relaciona a un método para vacunar cerdos contra la infección de Haemophilus parasuis, serovar tipo 4 al a) propagar clonalmente una o más células que son capaces de activar una respuesta inmune contra la infección de Haemophilus parasuis, serovar tipo 4, que protege al cerdo contra la infección de Haemophilus parasuis y b) combinar una cantidad inmunológicamente efectiva de las células con un portador veterinariamente aceptable en una forma adecuada para administración como una vacuna al cerdo y c) administrar como una vacuna de virus muertos. El cultivo de células es de una cepa de origen patogénico.
MX2016004178A 2013-10-04 2014-10-06 Vacuna de haemophilus parasuis para serovar tipo cuatro. MX373395B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361886991P 2013-10-04 2013-10-04
PCT/US2014/059330 WO2015051371A2 (en) 2013-10-04 2014-10-06 Haemophilus parasuis vaccine serovar type four

Publications (1)

Publication Number Publication Date
MX373395B true MX373395B (es) 2020-05-12

Family

ID=51830630

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004178A MX373395B (es) 2013-10-04 2014-10-06 Vacuna de haemophilus parasuis para serovar tipo cuatro.

Country Status (10)

Country Link
US (1) US9504740B2 (es)
EP (1) EP3052126A2 (es)
JP (1) JP2016533353A (es)
KR (1) KR20160065198A (es)
CN (1) CN105992592A (es)
BR (1) BR112016007390A8 (es)
CA (1) CA2926190C (es)
MX (1) MX373395B (es)
RU (1) RU2673715C2 (es)
WO (1) WO2015051371A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132183B2 (en) * 2007-03-09 2015-09-15 Newport Laboratories Modified live (JMSO strain) Haemophilus parasuis vaccine
CN105148262B (zh) * 2015-09-17 2018-07-10 龙岩学院 一种副猪嗜血杆菌五价灭活疫苗的制备方法
CN106234299A (zh) * 2016-07-26 2016-12-21 陆川县珊罗镇振兴猪场 一种猪的饲养方法
CN111793130B (zh) * 2019-03-20 2021-09-14 华中农业大学 一株副猪嗜血杆菌CdtB杂交瘤细胞及单克隆抗体应用
CN109971685B (zh) * 2019-04-09 2022-11-29 武汉轻工大学 一种副猪嗜血杆菌感染猪腹膜间皮细胞模型的构建方法
CN113018426B (zh) * 2021-02-07 2023-06-09 河南省农业科学院畜牧兽医研究所 用于制备副猪嗜血杆菌疫苗的组合菌株、八价灭活疫苗及其应用
US20250228924A1 (en) * 2024-01-11 2025-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Identification of g. parasuis immunogenic proteins and subunit vaccine comprising such
CN119776237A (zh) * 2025-02-10 2025-04-08 中国兽医药品监察所 一株副猪嗜血杆菌hp-1株及其在评价副猪嗜血杆菌4型灭活疫苗效力中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
CN101721696A (zh) * 2009-12-18 2010-06-09 西南民族大学 猪副嗜血杆菌血清4型、5型、13型三价油乳剂灭活疫苗
ES2617232T3 (es) 2010-04-23 2017-06-15 Intervet International B.V. Una vacuna que comprende células inactivadas de bacterias Haemophilus parasuis de serotipo 5
CN102908615B (zh) * 2011-08-01 2014-11-19 普莱柯生物工程股份有限公司 副猪嗜血杆菌病三价灭活疫苗及制备方法
CN102329746B (zh) 2011-08-16 2013-01-09 武汉科前动物生物制品有限责任公司 猪链球菌、副猪嗜血杆菌病二联灭活疫苗及制备方法
CN102499982B (zh) * 2011-12-21 2013-07-17 青岛易邦生物工程有限公司 副猪嗜血杆菌三价灭活疫苗的生产方法
CN103182077B (zh) * 2013-04-11 2015-05-13 江苏省农业科学院 一株血清4型副猪嗜血杆菌疫苗株的应用
CN103194413B (zh) 2013-04-11 2014-12-03 江苏省农业科学院 一株血清4型副猪嗜血杆菌疫苗株

Also Published As

Publication number Publication date
JP2016533353A (ja) 2016-10-27
WO2015051371A2 (en) 2015-04-09
RU2016116988A3 (es) 2018-05-22
BR112016007390A8 (pt) 2022-09-13
US9504740B2 (en) 2016-11-29
KR20160065198A (ko) 2016-06-08
EP3052126A2 (en) 2016-08-10
CN105992592A (zh) 2016-10-05
RU2673715C2 (ru) 2018-11-29
US20150098968A1 (en) 2015-04-09
WO2015051371A3 (en) 2015-07-09
BR112016007390A2 (pt) 2017-10-10
CA2926190A1 (en) 2015-04-09
RU2016116988A (ru) 2017-11-10
CA2926190C (en) 2023-05-09

Similar Documents

Publication Publication Date Title
MX373395B (es) Vacuna de haemophilus parasuis para serovar tipo cuatro.
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
HK1225631A1 (zh) 免疫原性中东呼吸综合征冠状病毒(mers-cov)组合物和方法
MX343048B (es) Oligodesoxinucleotidos inmunoestimulantes.
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
EA201500054A1 (ru) Аттенуированные вакцины против streptococcus suis и способы их получения и применения
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
EA201792407A3 (ru) Композиции, содержащие буфер, составы вакцин, которые содержат композиции, содержащие буфер, и пути их применения
MX346596B (es) Oligodesoxinucleotidos inmunoestimuladores.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
EA201391183A1 (ru) Способы усиления иммуногенспецифических иммунных ответов при помощи векторных вакцин
EA201590829A1 (ru) Новые мукозные адъюванты и системы доставки
MX2017005687A (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
CO6561819A2 (es) Vectores para vacunas y método para potenciar respuestas inmunes
MX345704B (es) Vacuna bovinas y métodos.
EA201790507A1 (ru) Способы и композиции для усиления иммунных ответов
IN2015MN00038A (es)
IN2015KN00516A (es)
MX2016007224A (es) Vacuna contra el circovirus porcino tipo 2.
EP4349367A3 (en) A vaccine for protection against streptococcus suis
MX2016002823A (es) Metodos y composiciones para vacunas vectorizadas virales.
GB2515222A (en) Use of flagellin as a vaccine
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

FG Grant or registration